AbbVie's $1.635B breakup fee to Shire, if paid, will run third highest ever

Breaking up is hard to do, and it can be expensive. AbbVie ($ABBV) is getting into record territory with the $1.635 billion breakup fee it will have to pay Shire ($SHPG) for canceling their $55 billion deal. The Wall Street Journal, citing Dealogic, says it would be the third largest breakup fee ever paid for killing a deal, and only the fourth to top $1 billion. One and two were the $4 billion AT&T paid T-Mobile for a canceled deal and the $1.8 billion Warner Lambert paid American Home products over a failed marriage. The only other to top the billion-dollar mark was a $1.2 billion feel dating to 2008 that was tied to a deal that fell apart over the buyout of Canadian telephone company BCE, The Wall Street Journal reports. Story (sub. req.) | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.